Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

SAP's journey began in 1972 when five former IBM employees founded the company in Germany. Initially focused on business ...

German software maker SAP (SAP) is now officially Europe’s largest publicly traded company with a market capitalization of Euros €313.70 ...

The global needles market is projected to grow from USD 8.1 billion in 2024 to USD 14.7 billion by 2035, at a CAGR of 6.1%.

SAP surpasses Novo Nordisk as Europes most valuable corporation at 500 trillion won SAP races to the forefront of European ...

Shares of Novo Nordisk rose 3.7% after the famed obesity drug maker ... said in a media call that 10-year bund yields would ...

As the crypto with the ninth-highest market cap, DOGE is far from in the doghouse, but it's still a risky play.

Add articles to your saved list and come back to them anytime. This story is part of the March 15 edition of Good Weekend. See all stories. We’ve become used to shopping precincts, office ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...

Tufts University professor Ibrahim A. Warde explains the origins and rise of the industry in Islamic Finance in the Global Economy. Rice University professor Mahmoud Amin El-Gamal explains the ...

European markets closed lower as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump’s ...